OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
May 11, 2022
Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.
Outsourcing partners are ready to fill the market need for greater cell therapies capacities.
May 10, 2022
908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.
May 09, 2022
Lonza and Integral Molecular will collaborate to better assess the risks of off-target binding of biologic drug candidates.
MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.
May 04, 2022
Standard BioTools’ new Hyperion+ Imaging System can process more samples and has lower limits of detection than their current product.
April 29, 2022
Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels.
April 20, 2022
Otsuka Pharmaceutical and Osaka University have entered an exclusive license agreement on a new anti-tumor antibody.
April 18, 2022
Thermo Fisher Scientific has launched its first GMP-manufactured Cas9 protein for clinical genome editing research.
April 13, 2022
VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.
April 12, 2022
Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for treatment of COVID-19.